vialaudit

affiliate disclosure · we earn commission on some vendor links. audits, scores, and rankings are independent — vendors do not pay for placement. read more →

VENDOR MATCHUP · AUDITED

Ascension Peptides vs BioTech Peptides

Two audits, side by side. Composite, subscores, shipping, payment, coupons.

Composite score

79
OF 100
VENDOR AUDIT

Ascension Peptides

US-domestic vendor with third-party (Kovera) COAs that absorbed much of the post-Amino-Asylum migration. It sells its GLP-1s under code names (R-10, T-10, S-5), which carries a regulatory-exposure deduction - the COAs name the real molecule even though the storefront does not. Strong public signals otherwise; scored on public data, with no test order placed.

vs
79
OF 100
VENDOR AUDIT

BioTech Peptides

Established US-domestic peptide synthesizer with a substantial catalog and same-day shipping. It does publish per-batch COAs - 84 of 89 product pages carry a downloadable certificate, most of them MZ Biolabs reports naming the client and lot, with a set of older SKUs on a lab-unnamed template. Public-data audit; we have placed no test order.

Subscore breakdown

7 METRICS
METRIC
ASCENSION PEPTIDES
BIOTECH PEPTIDES
Composite · weighted avg
79/100
vs
79/100
Purity / COA
87/100
vs
75/100
Shipping · stated domestic days
3.0d
vs
3.0d
Pricing
80/100
vs
82/100
Support
84/100
vs
74/100
Last reviewed
2026-10-12
vs
2026-10-12
Payment
card, ach
vs
crypto, card

Catalog overlap

ONLY ASCENSION PEPTIDES
retatrutidetirzepatidesemaglutide
BOTH
bpc-157
ONLY BIOTECH PEPTIDES
tb-500mots-cghk-cunad-plustesamorelinaod-9604

Active coupons

50% off
Ascension PeptidesEXCLUSIVEVIALAUDIT

50% off at checkout — exclusive vialaudit reader code

USE CODE
No active coupon for BioTech Peptides this cycle.

Other matchups

ALL COMPARISONS →
THE ROUNDUP · MONTHLY

Receipts in your inbox. Once a month.

New audits, expired coupons pruned, lab notes from vials still on the bench. No marketing. No lifestyle copy. Unsubscribe in one click.

14,200 SUBSCRIBERS·0 SPONSORED ITEMS·11 ISSUES SINCE LAUNCH